Clinical Trials of Stroke Therapy: Which Cells, Which Patients?

Clinical trials of stroke therapy: which cells, which patients?

Clinical Trials of Stroke Therapy

Despite recent advances in stroke prevention and acute stroke therapy, few treatments exist for reversal of fixed neurological deficits after stroke. Cellular therapy offers the possibility of improving neurological deficits months or even years after stroke. Animal studies provide evidence that such treatment may be effective. Many questions, however, remain unanswered regarding cellular thera...

Different Stroke Scales; Which Scale or Scales Should Be Use?

Background: There has been considerable development in the clinometric of stroke. But, researcher is concerned that some scales are too generic, inherently and the insight may not be provided. The current study was conducted to determine which scale or scales should be used in stroke survivors. Methods: We selected 67 studies which published between January 2010 and December 2018 from Up to d...

P71: Which Variables Predict the Response of Patients with Social Anxiety Disorder to Cognitive-Behavior Therapy?

Social anxiety (or social phobia) disorder is defined as a constant fear of being embarrassed or negatively evaluated in social situations or while doing activities in the presence of others. Several studies have examined the role of certain variables that might predict response to treatment and may affect treatment outcome. The purpose of this study was to identify predictive variables of chan...

Combination warfarin-ASA therapy: which patients should receive it, which patients should not, and why?

Combination warfarin-ASA therapy is currently used in approximately 800,000 patients in North America as long-term treatment for the primary and secondary prevention of atherothrombotic and thromboembolic diseases. Despite a potentially complementary action of anticoagulant and antiplatelet drugs, the use of combination warfarin-ASA therapy is not based on compelling evidence of a net therapeut...